Exosomes, new biomarkers in early cancer detection

Anal Biochem. 2019 Apr 15:571:1-13. doi: 10.1016/j.ab.2019.02.013. Epub 2019 Feb 15.

Abstract

Exosomes are endosomal-derived vesicles, playing a major role in cell-to-cell communication. Multiple cells secret these vesicles to induce and inhibit different cellular and molecular pathways. Cancer-derived exosomes have been shown to affect development of cancer in different stages and contribute to the recruitment and reprogramming of both proximal and distal tissues. The growing interest in defining the clinical relevance of these nano-sized particles in cancers, has led to the identification of either tissue- or disease-specific exosomal contents, such as nucleic acids, proteins and lipids as a source of new biomarkers which propose the diagnostic potentials of exosomes in early detection of cancers. In this review, we have discussed some aspects of exosomes including their contents, applications and isolation techniques in the field of early cancer detection. Although, exosomes are considered as ideal biomarkers in cancer diagnosis, due to their unique characteristics, there is still a long way in the development of exosome-based assays.

Keywords: Biomarker; Cancer; Diagnosis; Early detection; Exosomes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biomarkers, Tumor / analysis*
  • Biomarkers, Tumor / metabolism
  • Exosomes / chemistry*
  • Exosomes / metabolism
  • Humans
  • Neoplasms / diagnosis*
  • Neoplasms / metabolism*
  • Neoplasms / pathology

Substances

  • Biomarkers, Tumor